Voyager Acquisition Corp./Cayman Islands

VACH · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
20
SEC Filings

Business Summary

. Introduction We are a blank check company incorporated as an exempted company under the laws of the Cayman Islands on December 19, 2023, which will seek to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this Annual Report on Form 10-K as our initial business combination. On August12, 2024, Voyager Acquisition Corp. (the Company ) consummated its initial publ...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVACHdiscussed_in_filing Cybersecurity
topic_mentionVACHdiscussed_in_filing Trusted Computing
topic_mentionVACHdiscussed_in_filing Blockchain & Crypto
topic_mentionVACHdiscussed_in_filing Regulation
topic_mentionVACHdiscussed_in_filing Enterprise
topic_mentionVACHdiscussed_in_filing Healthcare & Bio
topic_mentionVACHdiscussed_in_filing Platform & Ecosystem
topic_mentionVACHdiscussed_in_filing Cybersecurity
topic_mentionVACHdiscussed_in_filing Trusted Computing
topic_mentionVACHdiscussed_in_filing Blockchain & Crypto
topic_mentionVACHdiscussed_in_filing Regulation
topic_mentionVACHdiscussed_in_filing Enterprise
topic_mentionVACHdiscussed_in_filing Healthcare & Bio
topic_mentionVACHdiscussed_in_filing Platform & Ecosystem
topic_mentionVACHdiscussed_in_filing Cybersecurity
topic_mentionVACHdiscussed_in_filing Trusted Computing
topic_mentionVACHdiscussed_in_filing Blockchain & Crypto
topic_mentionVACHdiscussed_in_filing Regulation
topic_mentionVACHdiscussed_in_filing Enterprise
topic_mentionVACHdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001829126-26-002162EDGAR50K words
2025-03-312024-12-310001829126-25-002231EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001829126-25-009211EDGAR21K words
2025-08-142025-06-300001829126-25-006315EDGAR—
2025-05-152025-03-310001829126-25-003727EDGAR—
2024-11-142024-09-300001829126-24-007548EDGAR—
2024-09-242024-06-300001829126-24-006435EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-180001829126-26-002460EDGAR2K words
2026-02-270001829126-26-001748EDGAR—
2026-02-030001829126-26-000900EDGAR—
2025-10-210001829126-25-008292EDGAR—
2025-09-050001829126-25-007177EDGAR—
2025-07-160001829126-25-005092EDGAR—
2025-04-230001829126-25-002874EDGAR—
2024-08-160001829126-24-005604EDGAR—
2024-08-140001829126-24-005510EDGAR—

20 total filings indexed. 4 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002006815
TickerVACH
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedE9

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1d0a5d2443b610e0fd38a0128b07a258a8cc923eeab52ab3a608bd6b225dc25d
parent: 7ccce922bd696a393ad0ce3f13fd169c4ca8cb4a407ed8a8c1ccdcaf870b9796
content hash: f170795f568df8cdb5771498ff8d1ee05208d93552a713c0f0489581d26196f1
signed: 2026-04-13T04:48:02.761Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf